Individualized cancer care needs to consider not only biology but patient demographics, environmental, socioeconomic and other factors, asserts Dr. Heidi Nelson.
The careers of Dr. Leonidas Berry and Dr. Sadye Curry, the first Black gastroenterologists in the U.S., were dedicated not only to medical care but also to fighting social injustices.
New treatment approaches should consider matching treatment intensity to inflammatory burden, Dr. David Rubin asserts.
Recent multisociety guidelines find limited data behind some processes that have become standard practice.
Dr. Shaukat believes that non-invasive screening tests will actually expand the need for colonoscopies.
Despite their differences, pancreatic cyst guidelines published by different groups have key similarities. Vanessa Shami, MD, simplifies the guidelines for clinicians.
Sarah Coughlin explains her study and its findings: across all ages, panel sizes, and races/ethnicities, the rate of clinically actionable variants was 7.8 percent or greater – supporting an expanded role for multigene panel testing in CRC patients.
New stool- and blood-based tests have the potential to overcome some of the barriers of initial colonoscopy screening.
Optimizing waste management can significantly reduce the carbon footprint of endoscopies.
COVID-19 revealed the fragility of the clinical trial system and scientific publishing.
